Skip to main navigation Skip to search Skip to main content

Anticancer Miliusane Derivatives (Granted)

Research output: Patent

Original languageEnglish
Patent number9,822,071
IPCA61-ZH-Mili-US03
Priority date5/06/12
Filing date1/06/17
Publication statusPublished - 21 Sept 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

User-Defined Keywords

  • Biotechnology
  • Breast cancer
  • Cancer
  • Colon cancer
  • Compound
  • Drug
  • Lung cancer
  • Medicine
  • Melanoma cancer
  • Miliusane
  • Oral epidermoid cancer
  • Prostate Cancer
  • bio_cell
  • bio_intestine
  • bio_lung
  • bio_prostate
  • bio_skin

Cite this